Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00910832Phase 4Completed
Phase 4, randomised, double-blind trial in dyschezia comparing Eductyl with Placebo (2 arms). Primary endpoint: Efficacy on VAS of intensity of symptoms at Day 21. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00910832.